SCHEMBL175262

SCHEMBL175262

COc1ccc(NC(=O)Nc2cccc3c2CCN3)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.55
NPC1 O15118 5/20 0.55
RAB9A P51151 5/20 0.55
MAPT P10636 3/20 0.55
PKM P14618 3/20 0.54
NFKB1 P19838 1/20 0.54
NFKB2 Q00653 1/20 0.54
RELA Q04206 1/20 0.54
TP53 P04637 2/20 0.54
MAPK1 P28482 1/20 0.54
MECP2 P51608 1/20 0.54
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
TSHR P16473 1/20 0.51
POLB P06746 2/20 0.49
HDAC3 O15379 1/20 0.48
EPHA2 P29317 1/20 0.48
HDAC4 P56524 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC7 Q8WUI4 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL175118 0.88 RAB9A (0.58) SMN1; SMN2NPC1RAB9AMAPTPKM
SCHEMBL174930 0.86 RAB9A (0.52) SMN1; SMN2NPC1RAB9AMAPTTP53
SCHEMBL4569778 0.84 MEN1 (0.53) SMN1; SMN2NPC1RAB9AMAPTTP53
SCHEMBL174936 0.84 MEN1 (0.51) SMN1; SMN2NPC1RAB9AMAPTTP53
SCHEMBL173758 0.82 SMN1; SMN2 (0.53) SMN1; SMN2NPC1RAB9AMAPTMEN1
SCHEMBL27807412 0.82 MAPT (0.51) SMN1; SMN2NPC1RAB9AMAPTPKM
SCHEMBL175067 0.81 MAPT (0.52) SMN1; SMN2RAB9AMAPTPKMMAPK1
SCHEMBL175419 0.81 MAPT (0.54) RAB9AMAPTMEN1KMT2AABCG2
SCHEMBL174986 0.79 KMT2A (0.52) SMN1; SMN2NPC1RAB9AMAPTPKM
SCHEMBL174238 0.78 DDX3X (0.52) NPC1RAB9AMAPTTP53MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611806-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS Ascepion Pharmaceuticals, Inc. (CN) 2013-07-10 EP claimed
WO-2012028106-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS ASCEPION PHARMACEUTICALS, INC. (CN) 2012-03-08 WO claimed
EP-2611806-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS Ascepion Pharmaceuticals, Inc. (CN) 2013-07-10 EP disclosed
WO-2012028106-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS ASCEPION PHARMACEUTICALS, INC. (CN) 2012-03-08 WO disclosed